Gloshell
成分辞典

成分辞典

C12-15 ALKANE/CYCLOALKANE/AROMATIC HYDROCARBONS

連携データベース 8 · 대한화장품협회 성분사전, 미국 EPA 화학물질 DB, 미국 EPA CompTox, 식약처 화장품 원료성분 +4

定義

Solvent naphtha (petroleum) heavy aromatic. A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C12-15

이 원료는 평균 12-15개의 탄소원자로 구성된 곧은 사슬, 고리형 및 방향족 탄화수소의 혼합물이다.

出典: 식약처 화장품 원료성분

別名・識別情報

C12-15 ALKANE/CYCLOALKANE/AROMATIC HYDROCARBONSINCIC12-15알케인/사이클로알케인/아로마틱하이드로카본식약처 표준명Solvent naphtha (petroleum), heavy arom.동의어
CAS No.化学物質登録番号
64742-94-5
EC No.EU化学物質目録番号
265-198-5
DTXSID米国EPA化学物質番号
DTXSID9028251

化粧品での役割

다른 성분을 녹이는 바탕SOLVENT

安全性・規制情報

국내 유독물 GHS 분류 없음 · 기존화학물질

出典: 한국환경공단 유독물 GHS 정보

Other restriction: ban substances that deplete the ozone layer

出典: EU CosIng 성분 목록

製品が実際に使っている用途

미국 EPA에 이 성분을 신고한 제품 36건의 용도입니다. 화장품 밖의 제품도 포함되어 있어, 위쪽 몇 줄이 이 성분의 주된 쓰임으로 읽힌다는 뜻입니다.

  • 용제16
  • 공정 보조4
  • 윤활제4
  • 바인더2
  • 계면활성제2
  • 소포제2
  • 연료 첨가2
  • 점도 조절1
나머지 용도 3개
  • 분산제1
  • 연료1
  • 유화 파괴1

出典: 미국 EPA CompTox

刺激・感作試験の記録

피부 시험 15건 · 눈 시험 8건이 기록되어 있습니다.

자극 높음으로 분류12건중간으로 분류1건낮음으로 분류18건

시험마다 결론이 갈립니다(가장 많은 결론의 비중 39%). 이 성분이 자극적이라고 단정할 수 없다는 뜻입니다. 원료 자체를 시험한 기록이고, 완제품에 든 농도에서의 자극성과는 다릅니다.

시험 23건 전부 보기
  • Severe Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Severe Irritation
    skin irritation: in vivo · Screening · other guideline: EPA Guidelines in FR Vol. 44, No. 145, pgs 44054-44093 according to
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to EPA OTS 798.4100 (Skin Sensitisation)
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: EPA guidelines in FR Vol. 44, No. 145, pgs. 44054-44093
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: EPA guidelines in FR Vol. 44, No. 145, pgs 44054-44093
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to EPA OTS 798.4100 (Skin Sensitisation) equivalent or similar to OECD Guideline 406 (Skin Sensitisation)
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to EPA OTS 798.4100 (Skin Sensitisation)
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Severe Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to
  • Severe Irritation
    skin irritation: in vivo · Screening · EPA OTS 798.4470 (Acute Dermal Irritation) according to
  • Category 2
    Skin Irritation · Screening
  • Severe Irritation
    skin irritation: in vivo · Screening · other guideline: EPA Guidelines in FR Vol. 44, No. 145, pgs. 44054-44093 according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · EPA OTS 798.4470 (Acute Dermal Irritation) according to OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
  • Classification not possible
    Skin Sensitization · Screening
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · EPA OTS 798.4500 (Acute Eye Irritation) equivalent or similar to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · EPA OTS 798.4500 (Acute Eye Irritation) according to
  • Category 2
    Eye Irritation · Screening
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · other guideline: EPA Guidelines in FR Vol. 44, No. 145, pgs. 44054-44093 according to

出典: 미국 EPA CompTox